FDA approves Abbott’s TriClip TEER device for tricuspid regurgitation
Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.
Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.
Čovek plemena bez treptaja je bio spreman da svoj život prinese na žrtvu Majci Stvoriteljki, bez koje života ne bi ni bilo. Ali, da li…
Euro VASC is an independant organization dedicated to promoting excellence in vascular access for structural cardiac & coronary interventions in Europe. Its aim is to…
Skip to main content We’ ve put some small files called cookies on your device to help us make improvements to our site. To improve…
AbstractBackground and Aims. Incident heart failure (HF) among individuals with chronic kidney disease (CKD) incurs hospitalizations that burden patients a
3M likes, 15K comments – purplecribstudios on April 23, 2024: “Play of the year #basketball #teamwork #uncleKEBO”.
Monday, May 20, 2024, is FAITH! Heart Health Day in Rochester. The proclamation builds upon the work of Rochester community members who research and do…
Cardiologist Jerry Blackwell, MD, president and CEO of MedAxiom, believes cardiologist can’t just focus on clinical decisions, as they also must be aware the financial…
The talk will cover optimal guideline-directed medical therapy in heart failure with reduced ejection fraction, the pitfalls in clinical trial interpretation…
This review discusses current evidence regarding the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of heart failure with preserved ejection fraction.